We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAMM:NASDAQNamib Minerals Analysis

Data as of 2026-06-18 - not real-time

$1.85

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Namib Minerals (NAMM) is trading at $1.85, well below its 52‑week high of $16.59 and far beneath the analyst consensus target of $9.50, implying a potential upside of over 400%. The stock sits under its 20‑day SMA (1.834) and 50‑day SMA (1.864) and is substantially below the 200‑day SMA (2.258), confirming a bearish price trend, while the RSI sits at 49.4 and the MACD line has just turned bullish (MACD histogram +0.0003). However, the market is extremely volatile (127% 30‑day volatility) and the beta of 2.87 signals amplified moves relative to the broader market, with volume trending downwards, adding to short‑term risk.
Fundamentally, NAMM’s PE of ~1.0, operating margin of 31.6%, and a forward EPS of $1.84 suggest strong profitability, yet its book value per share is negative and the DCF fair value ($0.92) is below the current price. The mill expansion at How Mine, highlighted in recent corporate news, aims to boost processing capacity and gold output, underpinning a medium‑ to long‑term growth narrative. Combined with a “Strong Buy” analyst rating and an estimated upside of 413%, the stock appears undervalued and positioned for significant upside, albeit with high volatility and geopolitical exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical positioning (price below all SMAs)
  • Decreasing volume and extreme short‑term volatility
  • High beta amplifying price swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Low PE (~1) and strong operating margins
  • Mill expansion project at How Mine expected to lift gold output
  • Analyst target price of $9.50 indicating >400% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Fundamental undervaluation relative to DCF and target price
  • Long‑term gold demand and exposure to high‑grade African assets
  • Potential upside from operational scale‑up and cash‑flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth5.10%
Profit Margin122.50%
P/E Ratio1.0
ROA14.57%
P/B Ratio-2.5
Op. Cash Flow$13.8M
Free Cash Flow$3.2M

Technical Analysis

TrendBearish
RSI49.4
Support$1.33
Resistance$2.70
MA 20$1.83
MA 50$1.86
MA 200$2.26
MACDBullish
VolumeDecreasing
Fear & Greed Index92.14

Valuation

Fair Value$0.92
Target Price$9.50
Upside/Downside413.51%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.87
Volatility127.80%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.